Trials / Completed
CompletedNCT02810756
Study With Improved Solubility Pazopanib
Proof of Principle and Pharmacological Phase 0 Study With Improved Solubility Pazopanib
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- The Netherlands Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The pharmacokinetics of a new formulation with Pazopanib will be studied. This will be done in a patient cohort of n = 12.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | New Pazopanib formulation |
Timeline
- Start date
- 2016-09-15
- Primary completion
- 2017-08-28
- Completion
- 2017-08-28
- First posted
- 2016-06-23
- Last updated
- 2017-09-11
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT02810756. Inclusion in this directory is not an endorsement.